Vor Biopharma Inc. (VOR)
NasdaqGS - NasdaqGS 即時價格。貨幣為 USD。
加入追蹤清單
收市：04:00PM EDT
收市後：
正在載入互動式股價圖表...
- Zacks
Why You Shouldn't Bet Against Vor Biopharma (VOR) Stock
Vor Biopharma (VOR) has seen solid earnings estimate revision activity over the past month, and belongs to a strong industry as well.
- Benzinga
Vor Bio's Trem-cel Shows Early Encouraging Data In Leukemia Patients
Vor Biopharma Inc (NASDAQ: VOR) presented updated data from patients treated in the VBP101 Phase 1/2a study of trem-cel (formerly VOR33) in acute myeloid leukemia patients. The time for neutrophil engraftment in all five patients treated with trem-cel (10-11 days) was similar to unedited transplants. All patients achieved high levels of myeloid donor chimerism by day 28. After achieving timely neutrophil engraftment and platelet recovery, patient 2 experienced secondary graft failure coincident
